Bowel Preparation in Colonoscopy: Lactulose vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, Multicenter Study.
| Condition | Colorectal Cancer Screening |
|---|---|
| Phase | Phase 4 |
| Sponsor | Hospital Civil de Guadalajara |
| Status | Completed |
| Enrollment | 449 participants |
| Interventions | Bowel preparation before colonoscopy, Bowel preparation before colonoscopy |
| Start date | Jul 20, 2024 |
| Completion date | Jul 31, 2025 |
| Results posted | Jul 28, 2026 |
Summary
The goal of this clinical trial it is to bowel the instestinal preparation with lactulose vs poliethylenglicol as better agent to have a quality colonoscopy and demostrate that lactulose is most efective, has a good tolerance and the patient would have a better satisfaction, so the question is: wich is the eficancy of lactulose in comparision with thepoliethylenglycol in the intestinal preparation for the colonoscopy?
Bowel Cleansing Was Assessed Using the Boston Bowel Preparation Scale (BBPS).
| Bowel Preparation With Lactulose Before de Colonoscopy | 7.21 ± 1.61 Score scale |
|---|---|
| Bowel Preparation With Plyethylenglycol Before the Colonoscopy | 7.08 ± 1.49 Score scale |
Open in BENITIONS View on ClinicalTrials.gov
Other trials for this condition
- CryoBalloon Ablation for Treatment of Duodenal Adenomas — Johns Hopkins University
- Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refract — Jennerex Biotherapeutics
- Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III — National Cancer Institute (NCI)
- Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps — National Cancer Institute (NCI)
- Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal — National Cancer Institute (NCI)
- Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating — National Cancer Institute (NCI)